252 related articles for article (PubMed ID: 29889065)
1. Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury.
Hu W; Tung YC; Zhang Y; Liu F; Iqbal K
J Alzheimers Dis; 2018; 64(3):709-722. PubMed ID: 29889065
[TBL] [Abstract][Full Text] [Related]
2. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
[TBL] [Abstract][Full Text] [Related]
3. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Tau Hyperphosphorylation Involving Lysosomal Enzyme Asparagine Endopeptidase in a Mouse Model of Brain Ischemia.
Basurto-Islas G; Gu JH; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2018; 63(2):821-833. PubMed ID: 29689717
[TBL] [Abstract][Full Text] [Related]
5. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
6. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
7. Subacute to chronic Alzheimer-like alterations after controlled cortical impact in human tau transgenic mice.
Zhang Y; Wu F; Iqbal K; Gong CX; Hu W; Liu F
Sci Rep; 2019 Mar; 9(1):3789. PubMed ID: 30846870
[TBL] [Abstract][Full Text] [Related]
8. Amphiphysin I cleavage by asparagine endopeptidase leads to tau hyperphosphorylation and synaptic dysfunction.
Zhang X; Zou L; Meng L; Xiong M; Pan L; Chen G; Zheng Y; Xiong J; Wang Z; Duong DM; Zhang Z; Cao X; Wang T; Tang L; Ye K; Zhang Z
Elife; 2021 May; 10():. PubMed ID: 34018922
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
10. Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma.
Ojo J; Eisenbaum M; Shackleton B; Lynch C; Joshi U; Saltiel N; Pearson A; Ringland C; Paris D; Mouzon B; Mullan M; Crawford F; Bachmeier C
Neurobiol Dis; 2021 Mar; 150():105237. PubMed ID: 33383188
[TBL] [Abstract][Full Text] [Related]
11. Does neuroinflammation drive the relationship between tau hyperphosphorylation and dementia development following traumatic brain injury?
Collins-Praino LE; Corrigan F
Brain Behav Immun; 2017 Feb; 60():369-382. PubMed ID: 27686843
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
[TBL] [Abstract][Full Text] [Related]
14. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.
Tran HT; LaFerla FM; Holtzman DM; Brody DL
J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616
[TBL] [Abstract][Full Text] [Related]
15. The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer's Disease.
Song M
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142134
[TBL] [Abstract][Full Text] [Related]
16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
17. Blockage of AEP attenuates TBI-induced tau hyperphosphorylation and cognitive impairments in rats.
Liu Y; Guo C; Ding Y; Long X; Li W; Ke D; Wang Q; Liu R; Wang JZ; Zhang H; Wang X
Aging (Albany NY); 2020 Oct; 12(19):19421-19439. PubMed ID: 33040048
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Profiling of Mouse Brains Exposed to Blast-Induced Mild Traumatic Brain Injury Reveals Changes in Axonal Proteins and Phosphorylated Tau.
Chen M; Song H; Cui J; Johnson CE; Hubler GK; DePalma RG; Gu Z; Xia W
J Alzheimers Dis; 2018; 66(2):751-773. PubMed ID: 30347620
[TBL] [Abstract][Full Text] [Related]
19. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
20. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
